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Summary 
Programmed cell death (PCD) is a physiological  process commonly defined by alterations  in 
nuclear morphology (apoptosis) and/or characteristic stepwise degradation of chromosomal DNA 
occurring before cytolysis. However, determined characteristics of PCD such as loss in mitochon- 
drial reductase  activity or cytolysis can be induced in enucleated cells, indicating cytoplasmic 
PCD control. Here we report a sequential disregulation of mitochondrial function that precedes 
cell shrinkage and nuclear fragmentation. A first cyclosporin A-inhibitable step of ongoing PCD 
is characterized by a reduction of mitochondrial transmembrane potential, as determined by specific 
fluorochromes (5,5',6,6'-tetrachloro-l,l',3,3'-tetraethylbenzimidazolcarbocyanine iodide; 3,3'di- 
hexyloxacarbocyanine  iodide). Cytofluorometrically purified cells with reduced mitochondrial 
transmembrane potential are initially incapable of oxidizing hydroethidine (HE) into ethidium. 
Upon short-term in vitro culture, such cells acquire the capacity of HE oxidation, thus revealing 
a second step of PCD marked by mitochondrial generation of reactive oxygen species (ROS). 
This step can be selectively inhibited by rotenone and ruthenium red yet is not affected by cyclo- 
sporin A. Finally, cells reduce their volume, a step that is delayed by radical scavengers, indicating 
the implication of ROS in the apoptotic process.  This sequence of alterations accompanying 
early PCD is found in very different models of apoptosis induction: glucocorticoid-induced  death 
of lymphocytes, activation-induced PCD of T  cell hybridomas, and tumor necrosis factor-in- 
duced death of U937 cells. Transfection with the antiapoptotic protooncogene Bcl-2 simultane- 
ously inhibits mitochondrial alterations  and apoptotic cell death triggered by steroids  or cera- 
mide. In vivo injection of fluorochromes such as 5,5',6,6'-tetrachloro-l,l',3,3'-tetraethylbenzimi- 
dazolcarbocyanine  iodide; 3,3'dihexyloxacarbocyanine  iodide; or HE allows for the detection of 
cells that are programmed for death but still lack nuclear DNA fragmentation. In particular, 
assessment  of mitochondrial ROS generation provides an accurate picture of PCD-mediated 
lymphocyte depletion. In conclusion, alterations of mitochondrial function constitute an impor- 
tant feature of early PCD. 
p rogrammed cell death (PCD) 1 is likely to occur during 
the whole lifetime of higher organisms, including early 
embryogenesis, to affect any cell type, and to constitute the 
normal fate of cells (1-3).  In spite of its physiological  and 
pathological importance, at least two major problems con- 
cerning PCD remain still elusive: (a) an operative definition 
of PCD, and (b) an efficient system to detect PCD in vivo. 
PCD is commonly defined by characteristic  morpholog- 
N. Zamzami and P. Marchetti  contributed  equally to this work. 
1 Abbreviations  used in this paper: CHX, cycloheximide; CsA, cyclosporin 
A; DCFH-DA, 2'-7'-dichlorofluorescin  diacetate;  AXglm, mitochondrial 
transmembrane  potential;  DEX,  dexamethasone;  DiOCr(3),  3,3'dihex- 
yloxacarbocyanine  iodide; Eth, ethidium; HE, hydroethidine; JC-1, 5,5',6,6'- 
tetrachloro-l,l',3,3'-tetraethylbenzimidazolcarbocyanine  iodide; mCICCP, 
carbonyl cyanide m-chlorophenylhydrazone;  NAO, 10-N nonyl-acridine 
orange; PCD, programmed cell death; PI, propidium iodide; PT, perme- 
ability transition;  ROS, reactive oxygen species. 
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Volume 182  August 1995  367-377 ical alterations (apoptosis) of the nucleus (heterochromatin 
condensation, nuclear fragmentation, and pyknosis), as well 
as a stepwise degradation of nuclear DNA,  first into sub- 
chromosomal fragments of 50-300 kbp, then into mono- or 
oligonucleosomal DNA fragments (1-3).  The notion that 
the nucleus would be a prime target of PCD is supported 
by a series of observations: (a) direct DNA damage may cause 
PCD;  (b) during apoptosis, nuclear disintegration precedes 
cytolysis; (c) in numerous experimental systems, a strict corre- 
lation between modulation of PCD and nuclear apoptosis 
is observed; (d) agents that inhibit DNA-degrading enzymes 
retard cytolysis of cells undergoing PCD; and (e) a number 
of PCD-regulatory oncogene products function in the nu- 
cleus (3, 4). However, recent studies invalidate the concept 
that alterations of the nucleus are obligatory events in PCD. 
Although agents that inhibit endonucleases such as aurin- 
tricarboxylic acid, zinc, and calcium chelators retard cytol- 
),sis in many systems, they do not ultimately prevent cell death 
(for review see reference 5). More importantly, PCD can be 
induced in enuchated cells (cytoblasts), provided that PCD 
is defined by assessing  nonnuclear parameters, a process in 
which reduction of mitochondrial activity precedes loss of 
membrane integrity and which is inhibited by the antiapop- 
totic protooncogene product Bcl-2 (6, 7). Therefore, events 
occurring independently or upstream of nuclear alterations 
have a major impact in the regulation and/or execution of 
PCD. 
One of the cardinal features of PCD is that, early during 
the process of death, cells undergo changes of membrane phys- 
icochemistry allowing for their recognition and elimination 
by neighboring cells (8). The very efficient removal of apop- 
totic cells in vivo probably accounts for the difficulty of de- 
tecting signs of advanced PCD,  including signs of nuclear 
apoptosis,  in vivo. This applies particularly to tissues endowed 
with a high phagocytic capacity, such as peripheral lymphoid 
organs, yet only partially to organs such as the thymus (9). 
Thus,  even during drastic apoptosis-inducing regimes, pe- 
ripheral lymphocytes isolated ex vivo fail to exhibit morpho- 
logical or biochemical alterations of the nucleus. This has 
been shown for in vivo injection of lymphocyte-depleting 
doses of glucocorticoids (10), superantigens (11), and certain 
cytostatic drugs (12) as well as for PCD-inducing HIV infec- 
tion (13,  14). 
Indirect evidence obtained recently suggests that alterations 
in mitochondrial physiology could be involved in PCD. First, 
reactive oxygen species (ROS) may participate as effector mol- 
ecules in PCD (15-17).  Although the source of these ROS 
accounting for PCD execution has not been characterized, 
it is known that the ubiquinone complex of the respiratory 
chain is a major source of superoxide radicals  (18). Second, 
lymphocytes undergoing  glucocorticoid  or  superantigen- 
induced death, as well as fibroblasts transfected with a temper- 
ature-sensitive mutant of SV40 large T cell antigen, exhibit a 
reduction in mitochondrial transmembrane potential (A~m) 
preceding nuclear DNA degradation (19, 20). The reduction 
in AXItm also concerns peripheral lymphocytes dying from 
PCD in vivo (19). Third, in a cell-free system, only mitochon- 
dria-enriched cytoplasma fractions are capable of inducing nu- 
clear apoptosis  (21).  Fourth, members of the Bcl-2 family 
of apoptosis-regulatory proteins are located preferentially in 
the outer mitochondrial membrane (22), and, at least in one 
system, localization to this compartment is indispensable for 
apoptosis modulation (23). 
Stimulated by these observations, we assessed mitochon- 
drial function in preapoptotic cells, i.e.,  cells that still lack 
nuclear signs of PCD yet are irreversibly committed to un- 
dergoing PCD.  We report here that a defined sequence of 
mitochondrial alterations-reduction  of A~m followed by 
enhanced generation of superoxide anions- is a constant fea- 
ture of early PCD.  The mechanisms accounting for mito- 
chondrial disregulation have been characterized. 
Materials  and Methods 
Animals and In Vivo Manipulations.  6- to 10-wk-old BALB/c 
females received  intraperitoneal injections of dexamethasone  (DEX, 
1 mg; Sigma Chemical Co., St. Louis, MO) or PBS as a vehicle 
control (200 #1) (10). In some experiments, animals received  intra- 
venous injections of nontoxic doses of the fluorochromes 5,5;6,6'- 
tetrachloro-l,l',3,Y-tetraethylbenzimidazolcarbocyanine  iodide 
(JC-1; 380 #M in 200 #1 PBS), 3,Ydihexyloxacarbocyanine  iodide 
(DiOC6(3); 100 #M), and/or hydroethidine (HE; 5 mM; Molec- 
ular Probes, Inc., Eugene, OK) 20-30  min before killing. 
Cells and Culture Conditions.  Splenocytes were prepared on ice, 
depleted from erythrocytes by hypotonic lysis as described (11), and 
maintained in RPMI 1640 medium supplemented with 10% FCS, 
t-glutamine,  Hepes, and antibiotics at 0-4~  until labeling and 
analysis. 2B4.11 T cell hybridoma cell lines stably transfected with 
an SFFu  vector containing the human bd-2 gene or the neo- 
mycin resistance gene only (24, 25) (kindly provided by Jonathan 
Ashwell, National Institutes of Health), U937 myelomonocytary 
cells, or WEHI-231 pre-B cells were incubated with the indicated 
apoptosis-inducing stimulus: 100 #M DEX; 50 #M ceramide  (Sigma 
Chemical  Co.)  (26); plastic-immobilized anti-CD3  (145-2Cll, 
coated to flat-bottomed 96-weU  microtiter plates [Nunc, Koskilde, 
Denmark] at 20 #g/ml in 100 mM Tris-HCl overnight); human 
rTNF-cr (0.4 ng/ml; Research Diagnostics, Inc., Flanders, NJ), 
and/or cycloheximide (CHX, 0.5 gg/ml) (27); or anti-IgM anti- 
bodies (5 #g/ml goat anti-mouse antiserum, Southern Biotech- 
nology Associates; Birmingham,  AL) (28). 
Cytofluorometry and Confocal Microscopy.  For in vitro labeling, 
cells were exposed for 10-15 min at 37~  to JC-1 (1 #M in PBS) 
(29), propidium iodide (PI; 5 #g/ml), merocyanine 540 (MC540, 
10 gg/ml) (30), 10-N nonyl-acridine orange (NAO; 100 nM, Mo- 
lecular Probes, Inc.) (31), 2',7'-dichlorofluorescin  diacetate (DCFH- 
DA;  5 #M) (15), DiOC6(3)  (40 nM) (32), and/or HE (2 gM) 
(33). As a control in some experiments, cells were labeled in the 
presence of the uncoupling agent carbonyl cyanide  m-chlorophenyl- 
hydrazone (mC1CCP, 50 #M; Sigma Chemical Co.). In a further 
series of control experiments, cells were incubated in the presence 
of tert-butylhydroperoxide  (50 mM, 2 min, RT; Sigma Chemical 
Co.), menadione (1 mM, 1 h, 37~  Sigma Chemical Co.), rote- 
none (1 raM, 1.5 h, 37~  or mCICCP (5 #M, 1 h, 37~  washed 
twice, and labeled with NAO. Unless otherwise indicated, in all 
experiments involving splenocytes, forward and side scatters were 
gated on the major population of normal-sized lymphoid cells. The 
frequency of cells having lost part of their chromosomal DNA 
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PI staining as described (34). Analyses were performed on a cyto- 
fluorometer (Epics Profile; Coulter Corp.,  Hialeah, FL) or on a 
confocal  microscope  (Acas 570; Meridian  Instruments,  Inc., 
Okemos, MI). 
Functional Studies of Purified Cell Populations.  For cytofluoro- 
metric purification, splenocytes were first depleted from cellular 
debris by density gradient (FicoU  Hypaque; Pharmacia LKB, Upp- 
sala, Sweden) centrifugation and then labeled with DiOC6(3) plus 
HE. Lymphocytes with normal size were gated on via the forward 
light scatter and were sorted immediately on a cytofluorometer 
(Elite; Becton Dickinson  and Co.,  San Jose, CA;  104 cells per 
second, windows as in Fig. 2) and recovered in complete medium 
on ice. Cells were incubated in the presence  or absence of cyclosporin 
A (CsA) (10 #M, Sandoz Pharmaceuticals Corp., East Hanover, 
NJ), rotenone (1 mM), ruthenium red (100 #M), digitonin (1/~M), 
antimycin A (50/~M), mC1CCP (50/zM), A23187 (2/~M), N-t- 
butyl-cr-phenylnitrone (50/~M), trolox (230 #M), and t-ascorbate 
(600/zM, Sigma Chemical Co.) at doses previously determined to 
give optimal effects. Cells (minimum 20,000 cells per tube) were 
kept in media supplemented with the indicated reagents for 15 rain 
at 4~  followed by relabeling with DiOC6(3) plus HE and reanal- 
),sis on the cytofluorometer. 
Results and Discussion 
Reduced A $rr, and Enhanced ROS  Generation Characterize 
DEX-primed Splenocytes In Viva  Freshly isolated splenocytes 
from DEX-primed mice exhibit intact DNA, even when re- 
covered during the phase of maximum reduction of splenic 
cellularity (12 h after injection of 1 mg DEX) (10,  19). Al- 
though these cells lack established signs of nudear PCD, they 
exhibit a diminution of A'~Irm, as quantitated by means of 
the fluorochrome  JC-1 (Fig.  1, A and B). JC-1 incorporates 
into mitochondria, where it either forms monomers (fluores- 
cence in green, 527 nm) or, at high transmembrane poten- 
tials, aggregates (fluorescence in red, 590 nm) (29). As com- 
pared with control cells, DEX-primed splenocytes exhibit a 
reduced JC-1 aggregation, a finding that indicates a drop in 
AXI/m. Such a staining pattern is obtained when splenocytes 
are incubated in vitro (15 rain, 37~  in the presence of  JC-1. 
Very similar results are seen when JC-1 labeling is performed 
in vivo by injecting a nontoxic dose of the fluorochrome into 
the animal, followed by a phase of in vivo incubation (30 
min) and ex vivo fluorescence analysis of freshly isolated cells 
(Fig.  1 A). This demonstrates that A'~ICm reduction actually 
does occur in vivo. Interestingly, DEX-primed cells with low 
A~Ifm display a synchronous reduction of JC-1 aggregation 
in all mitochondria-containing cytoplasma areas (Fig.  1 B). 
Uncoupling of DEX-primed cells with mC1CCP can fur- 
ther reduce JC-1 incorporation into cells by 0.3-0.5 logs (Fig. 
1 A), indicating that the A~m is not completely disrupted. 
In a further series of experiments, JC-1 was replaced by 
another fluorochrome, DiOC6(3),  which incorporates into 
mitochondria in  strict nonlinear dependence of A'~I/m and 
emits exclusively within the spectrum of green light (32). 
As reported (19), staining with DiOC6(3) revealed the pres- 
ence of a major subpopulation of A~m  l~  cells within the 
spleen of DEX-primed animals (see Figs. 1 C and 3 A). Cells 
were labeled simultaneously with HE, a substance that is ox- 
idized by ROS to become ethidium (Eth) and to emit red 
fluorescence (33). Splenocytes from DEX-primed animals con- 
tain two distinct DiOCr(3) l~  (Aff'm  1~  subpopulations, one 
that exhibits low ROS formation (HE-  cells),  comparable 
to that of AXI'mhis  h cells,  and another one that is character- 
ized by an enhanced HE ~  Eth conversion (HE + cells). The 
DiOC6(3)/HE  staining patterns obtained in vivo (see Fig. 
1 C) and in vitro (see Figs. 2 and 3 A) are comparable, indi- 
cating again that A~Ifm diminution and enhanced HE oxi- 
dation are not in vitro artifacts and actually occur in vivo. 
Since  DEX-primed  splenocytes  do  not  stain  with  2',7'= 
dichlorofluorescin diacetate (which measures H202 forma- 
tion [15, 33, 35]) (Fig.  2) yet become capable of converting 
HE into Eth (which is especiaUy sensitive to superoxide anions 
[33,  35]), it appears  that the ROS responsible for HE con- 
version is  superoxide anion. 
Minor  populations  of A~ICm  l~  or  HE +  cells  were also 
found in spleens from unprimed animals (Fig.  1), a fact that 
can be attributed either to  cell damage occurring during 
splenocyte purification or to spontaneous cell death, which 
is relatively frequent in the spleen (36, 37). Nonetheless, the 
frequency of such cells is strongly increased in DEX-treated 
animals. 
Sequential g~ ~F  m Reduction and ROS Generation in Preapop- 
totic Cells.  It may be assumed that DiOCs(3)/HE staining 
of DEX-primed splenocytes provides a snapshot of different 
stages  of ongoing  preapoptosis.  To  determine  the  exact 
precursor-product relationship of these stages,  the popula- 
tions defined by simultaneous labding with DiOCr(3) and 
HE were purified by cytofluorometric sorting while gating 
on normal-sized ceils in the forward light scatter (Fig. 3 A). 
Transmission electron microscopy revealed no major altera- 
tions in nuclear morphology in any of these fractions (not 
shown). Upon relabeling and reanalysis,  purified cells cul- 
tured in vitro for 1 h at 37~  but not controls kept at 4~ 
exhibit characteristic phenotypic alterations. A minor popu- 
lation of A~mhighHE=  ceils becomes A~rml~  A frac- 
tion of A~ml~  cells acquires a A~ml~  + phenotype. 
A~ml~  + splenocytes conserve their phenotype with the 
exception of size; forward scatter analysis reveals that a high 
percentage of these cells collapses during short-term in vitro 
culture (Fig. 3 A) and thus exhibits a characteristic of incip- 
ient apoptosis (38). None of the purified populations contains 
a significant percentage (<2%) of subdiploid cells, as assessed 
by analysis of the DNA content. In vitro culture,  followed 
by assessment of DNA content, reveals that  A~ml~  + 
cells are the first to undergo nuclear fragmentation, whereas 
their HE- precursors are comparatively resistant to nuclear 
DNA loss  (Fig.  3 B).  These results provide evidence that 
DEX-primed splenocytes first reduce their A'~Irm and then 
hyperproduce ROS, reduce in size, and finally undergo endo- 
nucleolysis. Kinetic analysis of DEX-induced splenocyte death 
corroborates this scenario (Fig. 3 C), which is not restricted 
to one particular PCD induction system (see below). It ap- 
pears that labeling with HE provides a more accurate picture 
of  ongoing  cell  depletion  than  assessment  of  AXlrm by 
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precedes the DEX-driven loss in splenic cellularity, enhanced 
HE staining  is observed only when  the number  of splenic 
cells is  actually diminishing  (Fig.  3  C). 
Different Mechanisms Are Involved in zl ~,~  Reduction and 
Mitochondrial ROS Generation.  The notion  that  the A~m 
I~  and  A~ml~  +  phenotypes  constitute  discrete 
stages of preapoptosis is underscored by manipulations selec- 
tively affecting either the loss in AgCm or the production of 
ROS (Fig. 4). FACS|  cells were cultured 1 h in the 
presence of different substances known  to affect mitochon- 
drial function,  followed by relabeling with  DiOC6(3)/HE 
and reanalysis.  In the model of DEX-induced splenocyte apop- 
toffs,  the  transition  from  the  Aff'mhighHE -  to  the  A~m 
I~  state,  which normally ensues in in vitro culture at 
37"C (Fig. 3 A), is prevented by CsA.  Thus, CsA, an agent 
previously shown  to inhibit  the opening of mitochondrial 
inner membrane megachannds in isolated mitochondria (39) 
and in anoxia-damaged hepatocytes or myocardial ceils (40, 
41), also inhibits PCD-associated A~'m loss in lymphocytes. 
This  may indicate  that,  during  the  initial  phase  of PCD, 
A~m reduction involves a mitochondrial permeability tran- 
sition  (PT)  mediated  by  mitochondrial  inner  membrane 
megachannels. 
Although CsA inhibits Affrm  ~  reduction, it does not affect 
the  transition  from  the  A~ml~  -  to  the  A~ml~  + 
stage. ROS production by A~m  l~  cells is selectively blocked 
by inhibition of mitochondrial electron transport in complex 
I by rotenone as well as by the hexavalent cation ruthenium 
red, a specific inhibitor of the mitochondrial calcium uniport 
(42,  43).  To allow for optimal  diffusion of ruthenium  red 
to its site of action, the inner mitochondrial membrane, ceils 
must be partially permeabilized with digitonin (44). Digitonin 
does not cause a reduction in Al/m per se,  since it only per- 
meabilizes  cholesterol-containing  membranes  (45)  and  the 
inner mitochondrial membrane is essentially cholesterol free 
Figure  1.  Assessment of AC/m in splenic T cells from DEX-primed 
animals. (A) In vivo assessment of DEX-induced shift in Aa/m. 12 h after 
intraperitoneal administration of DEX or PBS as vehicle  control, animals 
were injected intravenously with JC-1. After 30 min of in vivo incuba- 
tion, splenocytes  were recovered  and subjected to cytoftuorometry while 
gating on normal sized lymphocytes. As a control, cells were incubated 
before analysis with mC1CCP (50/~M;  15 min, 37~  an uncoupling 
agent that completely abolishes the AC/m. In addition, DNA from 2  x 
106 splenocytes  (S) from PBS- or DEX-primed animals was subjected to 
gel electrophoresis  as described (11), not revealing  any DNA degradation 
among DEX-primed splenocytes  (insets). Thymocytes  (T), which, in con- 
trast to peripheral  lymphocytes,  do undergo massive  DNA fragmentation 
in vivo (9) in response  to DEX, were included as positive  controls. Results 
are representative  of  three independent experiments. (B) Confocal  micros- 
copy of splenocytes  labeled ex vivo. Splenic  T cells from animals injected 
with PBS or DEX as above were stained in vitro with the fluorescence 
dye JC-1 (1/~M, 15 min, 37~  As a control, cells were labeled with 
JC-1 in the presence  ofmC1CCP (5/~M; 15 min, 37~  (C) Simultaneous 
in vivo detection of A~m and ROS production. After intraperitoneal ap- 
plication of DEX or PBS (12 h before analysis), animals were injected in- 
travenously  with DiOC6(3) and HE (20 min before  analysis), respectively, 
followed  by cytofluorometric  analysis. Mitochondria  were uncoupled  with 
the protonophore mC1CCP, as in/g 
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Figure  2.  Simultaneous assessment 
of KOS generation by HE and DCFH- 
DA.  Splenocytes from  control  and 
DEX-primed animals (1 mg i.p., 12 h 
before analysis) were labeled in vitro 
with  HE  (2  #M)  and  DCFH-DA 
(5 #M) for 10 min at 37~  followed 
by cytofluorometric analysis. As a posi- 
tive control for DCFH-DA labeling, 
cells from PBS-treated mice were in- 
cubated for 2 min in the presence of 15 
mM H202  and washed twice before 
labeling￿9 
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Figure 3.  Rehtionship between A~/m reduction and ROS generation. 
(.4) Determination of the precursor product relationship of FACS~ 
populations. Splenocytes  from DEX-primed BALB/c mice (1 mg i.p., 12 h 
before analysis) or vehicle controls were kept on ice and incubated with 
a mixture of DiOC6(3) (40 nM in PBS) and HE (2 #M) for 10 rain at 
(46). Complete uncoupling of mitochondria by addition of the 
protonophore mC1CCP accelerates KOS production. Similarly, 
the calcium ionophore A23187 accelerates the transition from 
the A~mbWHE- to the A~m]~  + stage￿9 Therefore, ROS 
responsible  for  HE  -~  Eth  conversion  are  produced  by 
mitochondria in a calcium-dependent  fashion. Accordingly, 
control  substances  that  affect  nonmitochondrial  pathways 
of ROS  generation  fail  to  affect  the  transition  from  the 
DiOC6(3)]~  to  the  DiOC6(3)I~  §  stage.  This  ap- 
plies to inhibitors of lipoxygenase (10 #M nordihydroguaiaretic 
add), cycloxygenase (500 #M indomethacin), monoamine oxi- 
dase  (1.5  mM  pargyline),  xanthine  oxidase  (300  #M  al- 
lopurinol),  nitric  oxide  synthetase  (100  #M  NG-methyl-t- 
arginine), pyrrolidinedithiocarbamate (I00 #M), which stops 
the Fenton reaction converting HzO2 into superoxide anions, 
and diphenylene iodonium (0.1/~M), an inhibitor of NADPH 
oxidase and other flavin oxidases (47)  (not shown).  In con- 
trast, antimycin A, an agent that leads to increased superoxide 
anion generation at sites proximal to the complex III of elec- 
tron transport (48), enhances the A~ml~  -/A~ml~  + 
transition (Fig. 4). This underscores that electron transport 
is  still going  on in A~m  l~  cells. 
At a final level, the shrinkage of A~mI~  + calls is selec- 
tively inhibited by substances that suppress mitochondrial ROS 
generation (rotenone,  ruthenium  red), as well as by antiox- 
idants  such  as the vitamin E  derivative trolox,  alone or in 
37~  immediately before cytofluorometric analysis. Purified cells from 
windows 1-3 were kept for 60 rain at 4~  or 37~  followed by relabeling 
and reanalysis under identical conditions. Among cells from windows 1 
and 2, no significant (<10%) reduction in cell size was observed during 
1 h of culture at 37~  (not shown). Accordingly, gating on normal-sized 
cells was maintained during reanalysis of these populations. In contrast, 
upon reanalysis  of fraction 3, a high portion of cells displayed  a temperature- 
dependent reduction in size (lower  panel). Results are typical for six inde- 
pendent experiments. (B) Loss of nuclear DNA of different cell fractions. 
Cells purified as in A were cultured during the indicated interval, followed 
by determination of the frequency of subdiploid cells. (C) Kinetics of the 
loss in A~m and ROS production from DEX-pfimed splenocytes. Mice 
received DEX injections (1 mg i.p.). After the indicated interval, spleno- 
cytes were recovered and labded ex vivo as in A. DNA hypoploidy con- 
cerns <1% of cells for any time point. Moreover, the reduction in viable 
splenocytes recovered (mean values of three animals) is computed. 
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Figure  4.  Modulation of progressing preapoptosis reveals independent 
mechanisms of A~m reduction and ROS generation. DEX-primed spleno- 
cytes were sorted cytofluorometrically into three normal-sized populations: 
DiOC6(3)~shHE - ,  DiOC6(3)I~  - ,  and DiOC6(3)I~  +  cells,  fol- 
lowed by in vitro culture (1 h, 37~  relabeling, and reanalysis  (manipu- 
lation similar as in Fig. 3 A). The transition to the immediately posterior 
stage of preapoptosis is indicated for each subpopulation  in different con- 
ditions of in vitro culture. Background  values obtained  in control cultures 
kept at 4~  (Fig. 3 A) were subtracted from experimental values. Results 
(•  are pooled  from five  different experiments. Each agent was evalu- 
ated at least three times. Ruthenium red was diluted in DMSO (final con- 
centration of 1%). Arrows indicate a significant (P <0.01, Student's t test) 
increase or decrease of transition processes as compared with controls. 
combination with t-ascorbate, or the radical  scavenger N-t- 
butyl-oz-phenylnitrone  (Fig.  4).  This observation confirms 
that  ROS are PCD effector molecules. 
In synthesis, these data indicate that  A~m reduction and 
enhanced mitochondrial ROS generation indeed represent two 
clearly distinct phases of the preapoptotic process. Only after 
A~  has dropped are ROS generated and do they partici- 
pate in the perturbation  of mitochondrial  membranes  (see 
below), as well as in later manifestations of PCD such as cell 
shrinkage. 
Enhanced  R OS Generation  Is Accompanied  by Local Membrane 
Perturbation but Precedes  Alterations of the Cell Membrane.  To 
determine whether ROS generated in mitochondria have a 
direct local impact on mitochondrial membranes, the amount 
of intact cardiolipin, a molecule restricted to the inner mito- 
chondrial membrane (46, 49), was determined by means of 
the fluorochrome NAO.  NAO interacts  stoichiometrically 
with intact cardiolipin (1:2) (31), and this interaction is not 
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influenced by the mitochondrial energy state (50). As shown 
in Fig. 5 A, only two major populations can be detected in 
the spleen, one characterized by low HE -~ Eth conversion 
and normal NAO staining (NAOai# cells) and a second one 
marked by enhanced HE oxidation and reduced NAO staining. 
The  frequency  of  HE+NAO l~  cells  increases  in  DEX- 
primed spleens.  Control experiments (Fig. 5 B) demonstrate 
that  the  reduction  of A~tm  by  incubation  with  rotenone 
does not affect the labeling with NAO. In contrast, incuba- 
tion of cells with an exogenous source of ROS (tert-butyl- 
hydroperoxide) or inducers of ROS generation (menadione 
or mCICCP) causes a reduction in NAO staining.  This reduc- 
tion is immediate after a short incubation with tert-butylhydro: 
peroxide (2 min,  Fig.  5 B) or an equivalent concentration 
of H202 (2 min,  not shown),  suggesting that  it could re- 
sult from direct cardiolipin oxidation. Thus, the ROS respon- 
sible for HE ~  Eth conversion may be suspected of causing 
an immediate oxidation of mitochondrial compounds. More- 
over, the fact that most if not all HE- cells exhibit a normal 
NAO~s  h phenotype (Fig.  5 A) indicates  that  A~ml~ 
cells  still  possess normal inner mitochondrial  membranes. 
As shown above, DEX-primed splenocytes of normal size 
contain a significant number of HE + cells (Figs.  1 C, 2, 3 
A,  and 5 C),  which undergo cell shrinkage  upon in vitro 
culture (Fig. 3 B). In contrast, only comparatively small cells 
exhibit alterations of the cell membrane that have been reported 
to accompany PCD: an enhanced cell permeability, as indi- 
cated by incorporation of PI (51), and increased labeling with 
MC540 (30, 52) (Fig. 5 C). MC540 is thought to measure 
apoptosis-associated alterations in lipid packaging (30), such 
as aberrant  exposure of phosphatidylserine  residues on the 
outer leaflet of the membrane (53) mediating the phagocyte- 
mediated recognition and removal of apoptotic cells. The frac- 
tion  of small  PI  interme~tahish MC540 +  splenocytes was in- 
creased in DEX-primed  animals  (Fig.  5 C). 
In synthesis, this set of data suggests that ROS generation 
causes an immediate damage of the inner mitochondrial mem- 
brane,  yet it precedes cells shrinkage  and associated plasma 
membrane  alterations. 
Correlation between  Mitochondrial  Perturbation and Apoptosis 
Induction in Different In Vitro Models of PCD  Reduction in 
A~m  and  subsequent  KOS hyperproduction  are observed 
in several in vitro models of physiological PCD, i.e., models 
in which nontoxic agents were used to induce PCD in sus- 
ceptible target cells: TNF-a in U937 cells and anti-IgM in 
WEHI 231 pre-B cells,  as well as CD3 cross-linking in T 
cell hybridomas (Fig.  6). Ceramide, a second messenger in- 
volved in the mediation of some PCD types (26, 54), also 
causes these effects. In all of these systems, alterations in mito- 
chondrial function precede DNA fragmentation and nuclear 
DNA loss. Thus, it appears that mitochondrial derangement 
is a constant feature of PCD occurring independently of the 
PCD-inducing  stimulus. 
In T  cell hybridomas,  transfection-enforced hyperexpres- 
sion of the antiapoptotic protooncogene bcl-2 retards  AXifm 
diminution  and ROS generation,  as well as subsequent nu- 
clear hypoploidy in  response to DEX  and ceramide.  This 
finding is in agreement with previous data suggesting a Bcl- ￿9  DIOC6(3)I~ 
so  O  m~diploid cells 
q. ,.,~ 
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Figure  5.  Increased  mitochondrial KOS generation is accompanied by 
reduced staining with NAO, yet it precedes apoptosis-associated altera- 
tions of the plasma membrane. (A) Simultaneous detection of ROS gener- 
ation and cardiolipin. Cells from DEX-primed mice (1 rag, 12 h before 
analysis) or controls were stained simultaneously with HE and NAO as 
described in Materials and Methods, followed by cytofluorometric anal- 
ysis. NAO fluorescence  was exclusively  determined in FL1, and, after ap- 
propriate compensation, HE fluorescence  was determined in FL3. (B) Effects 
of KOS generation of NAO staining. Control splenocytes  were incubated 
in the presence of tert-butylhydroperoxide  (5 raM, 2 min, RT), menadione 
(1 raM, 1 h, 37~  mC1CCP (50 #M, 1 h, 37~  or rotenone (1 raM, 
1.5 h, 37~  washed, and stained with NAO. Parallel stainings with HE 
and DiOC6(3) revealed that rotenone-treated cells had a DiOC6(3)~HE-, 
whereas  menadione  gave rise  to  a  DiOC6(3)~~  + phenotype  (not 
shown). (C) Correlation between cell size and PCD-associated changes. 
Cells from control and DEX-treated animals were labeled with HE, PI, 
or MC540. The cell size determined by means of the forward scatter (linear 
scale) was plotted against fluorescence (logarithmic scale). Data are repre- 
sentative of three different experiments. 
2-mediated reduction of KOS production (16) and/or ROS 
action (15) during apoptosis. In contrast, Bd-2, which is com- 
paratively inefficient in preventing antigen receptor-induced 
PCD (24,  25, 28),  does not affect the anti-CD3-triggered 
A~  reduction, ROS production, and loss in nudear DNA 
ofT cell hybridomas (Fig. 6). This underscores the strict corre- 
lation between PCD and mitochondrial alterations. Moreover, 
these data suggest that AXFm  reduction and subsequent ROS 
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generation are involved both in Bcl-2-inhibited and in Bcl- 
2-resistant pathways of PCD. 
Concluding  Remarks.  In this paper, we decipher a sequence 
of discrete steps of preapoptosis, i.e., of PCD stages occur- 
ring before the nucleus or nuclear DNA are fragmented (Fig. 
7). The first alteration that distinguishes cells induced to un- 
dergo PCD from normal cells is a fall in A~m, detectable by 
reduced labeling with DiOC6(3) or diminished JC-1 aggre- 
gation.  Thereafter,  uncoupled  mitochondria  hyperproduce 
superoxide anion (detectable by enhanced HE -~ Eth conver- 
sion) and simultaneously exhibit a perturbation of the inner 
mitochondrial membrane (detectable as reduced labeling with 
NAO). At this stage, cells still possess a normal size, normal 
dye exclusion capacity (measured by labeling with PI), and 
normal cell membrane characteristics (assessed by MC540). 
These parameters  are only affected in a  subsequent  step of 
preapoptosis, the last detectable in vivo, which involves near 
simultaneous  cell shrinkage,  increase in  membrane perme- 
ability, and alteration of lipid packaging, yet still intact DNA. 
When integrated with the data available in the literature, 
the results reported in this paper strongly suggest that reduc- 
tion  of A~m,  concomitant  with uncoupling  of mitochon- 
drial electron transport  and ATP synthesis (20,  55),  causes 
increased generation of ROS, which, in turn,  are important 
mediators of apoptosis (15-17).  In accord with this hypoth- 
7O 
~0 
4O 
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Figure 6.  Correlation between AC/m  reduction, ROS generation, and 
nuclear apoptosis in different systems. 2B4.11 T cell hybridoma cell lines 
stably transfected with human bd-2 gene or the vector only (Neo), U937 
myclomonocytary cells, or WEHI-231  pre-B cells were incubated with 
the indicated apoptosis-inducing stimulus: 100 #M DEX;  50 #M cera- 
mide; immobilized anti-CD3; TNF-o~  (0.4 ng/ml) plus CHX (0.5 #g/ml); 
or anti-IgM antibodies (5 #g/ml goat anti-mouse antiserum). After the 
indicated interval, the frequency of DiOC.6(3)~hFIE-, DiOC~(3)I~  - 
and DiOC6(3)I~"HE  + was assessed. Loss in nuclear DNA content was 
measured by PI staining of ethanol-permeabilized cells. esis,  direct inhibition  of mitochondrial DNA  replication, 
blockade of the respiratory chain, and induction of mitochon- 
drial ROS generation cause PCD in lymphocytes and neurons 
(15, 37, 56, 57). Moreover, blockade of mitochondrial pro- 
tein synthesis with doxycycline  as wall as inhibition of mito- 
chondrial electron transport with low doses ofrotenone renders 
glucocorticoid-resistant cell lines sensitive to PCD induction 
by DEX (55, 58).  The A~m reduction, which we observe 
as a constant feature of early PCD, is per se sufficient to im- 
pair mitochondrial ATP generation, as well as mitochondrial 
DNA and protein synthesis (59). Accordingly, thymocyte  PCD 
is accompanied by a strong inhibition of ATP synthesis (60), 
as well as by a transcription blockade selectively affecting the 
entire mitochondrial  genome  (61).  Taken  together,  these 
findings argue in favor of a scenario in which breakdown of 
mitochondrial function, perturbation of intermediate metab- 
olism, and/or ROS generation are involved in extranuclear 
PCD control. Each of the phenomena reported in this paper, 
loss of mitochondrial function and ROS generation, would 
suffice to entail cell death, thus conveying a pleiotropic effector 
phase to PCD execution. 
It has been shown previously that a human fibroblast cell 
line selected in EthBr to lose mitochondrial DNA (po cells) 
could be induced to die from apoptosis in response to stauro- 
sporine or growth factor withdrawal (62). po cells compen- 
sate for a respiratory defect via enhanced anaerobic glycolysis 
and thus rely on the provision of excess glucose or pyruvate. 
The action of the ADP/ATP translocator to import ATP into 
mitochondria and/or to succinate dehydrogenase allows for 
the maintenance of a Agrm that  is indistinguishable from 
that of p + controls (63),  suggesting that,  even in pO cells, 
a normal A~  is indispensable for cell survival.  L929 cells 
lacking mitochondrial DNA (po cells) have been reported to 
be relatively resistant to the cytotoxic effect of TNF, and this 
resistance has been attributed to a reduced generation of ROS 
species (64).  In contrast, po L929 cells die when exposed to 
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Figure 7.  Phenotypes  and precursor- 
product relationship  of  different  stages  of 
preapoptosis. The diagram summarizes 
the data obtained  on in vivo  DEX-primed 
splenocytes (Figs. 3-5). Moreover,  it is 
confirmed  in various in vitro systems  of 
apoptosis induction (Fig. 6). 
a combination of TNF and CHX (64). In accord with these 
data, we observed that po U937 cells undergo apoptosis after 
stimulation with TNF and CHX,  although with a certain 
delay as compared with normal p + controls. Interestingly, 
p~ U937 cells behave exactly as p+ controls in the sense that 
they manifest an early Aff'~ loss  during the TNF/CHX- 
driven apoptotic process that precedes DNA fragmentation. 
In addition, such cells hyperproduce KOS, but at a reduced 
rate as compared with p+ cells (Marchetti, P., N. Zamzami, 
M. Castedo, T. Hirsch, and G. Kroemer, manuscript in prep- 
aration), in contrast to normal cells (Fig. 4). This may indi- 
cate that the mere loss of mitochondrial function as manifested 
by a AXIrm 10$S, even when mitochondrial ROS generation 
is abolished or reduced, can participate in the induction of 
apoptosis.  In accord with this speculation, it has been shown 
that certain types of PCD, e.g., APO-1/Fas-induced apop- 
tosis,  do not require mitochondrial ROS generation (65). 
As to the mechanism of apoptosis-associated mitochon- 
drial disregulation,  it  is  tempting to  speculate that  PT,  a 
phenomenon that has been studied for decades in isolated 
mitochondria, might be involved in the early step of mito- 
chondrial disregulation (66). In numerous systems, PT is par- 
tially inhibited by CsA via a mechanism involving a mito- 
chondrial cyclophilin but not calcineurin (39-41,  66,  67). 
Similarly, CsA retards the initial phase of mitochondrial dis- 
regulation accompanying apoptosis of DEX-primed spleno- 
cytes (Fig. 4) and TNF-treated U937 cells (not shown). PT 
involves opening of mitochondrial megachannels (also termed 
PT pores) localized in the inner membrane, a concomitant 
increase in permeability to solutes with molecular masses 
<1,500 daltons, uncoupling with collapse of Agm, and ces- 
sation of ATP synthesis. Interestingly, PT transition has self- 
amplificatory properties,  in  the  sense  that  loss  of matrix 
Ca  2+  and  glutathione,  depolarization  of the inner  mem- 
brane, and increased oxidation of thiols, which result from 
megachannel opening, themselves increase the megachannel 
gating potential (39, 42). This explains how PT can spread 
in a wavelike fashion through populations of isolated mito- 
chondria (66). Opening of the PT pores might mark a point 
of no return during the effector phase of ongoing PCD and 
could account for the apparent synchronization of A~m loss, 
which affects all mitochondria within a cell simultaneously. 
Synchronization  of AXIZm lOSS between  mitochondria  has 
been observed in lymphocytic PCD (Fig. 1 B) as well in rela- 
tively large cells,  such as sympathetic neurons undergoing 
apoptosis after withdrawal of nerve cell growth factor from 
cultures (Zamzami, N., and P. Marchetti, unpublished ob- 
servation). Although CsA is an effective inhibitor of A~m 
loss in short-term experiments (Fig.  4), CsA fails to main- 
tain mitochondrial functions and thus does not prevent DEX- 
induced PCD during longer incubation periods (68). In con- 
sequence, additional CsA-resistant mechanisms could partic- 
ipate in apoptotic PT, as has been reported for anoxia-induced 
hepatocyte injury (41). Shortly after the Agtm drop, within 
a few hours (Fig. 3), superoxide anion radicals are generated 
by an uncoupled respiratory chain via a process that requires 
ruthenium  red-sensitive  calcium  cycling  (Fig.  4).  Over- 
produced KOS might irreversibly inactivate mitochondrial 
374  Mitochondria  in Early Apoptosis electron transport chain components and ATPase (69). This 
may explain why HE + cells have an even lower A~m than 
purified HE-Agtmhis  h cells  (Fig.  3).  Moreover, KOS pro- 
duced by mitochondria accelerate cellular shrinkage, one of 
the first alterations accompanying apoptosis (38), as indicated 
by experiments involving radical  scavengers  (Fig.  4). 
Although FF might be the consequence of  multiple different 
pathways reported to participate in PCD regulation, including 
an elevation of cytosolic calcium levels (70), oxidation of cel- 
lular thiols (67),  or depletion of intracellular glucose stores 
(71), the exact molecular mechanisms responsible for apop- 
totic VI" remain elusive. Nonetheless, the present data pro- 
vide dear evidence  that alterations of mitochondrial physi- 
ology are a constant feature of very different systems of PCD 
induction, mark a phase of irreversible commitment to death, 
precede  nuclear apoptosis,  and allow for the in vivo detec- 
tion of ongoing PCD. ROS generated from a partially un- 
coupled respiratory chain actively participate in the effector 
phase of PCD, and it is possible that mitochondria form part 
of the cytoplasmic PCD control instance that has been postu- 
lated by several groups (6, 21). These notions strongly sug- 
gest that an addendum should be joined to the current defini- 
tion of apoptosis:  Physiological PCD is a process involving 
an active  shutdown of mitochondrial function. 
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